Effect of Tetracaine on Intraocular Pressure in Normal and Hypertensive Rabbit Eyes by Sarchahi, Ali Asghar & Bozorgi, Hooman
29
Original Article
JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2012; Vol. 7, No. 1
Effect of Tetracaine on Intraocular Pressure in 
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Purpose: To evaluate the effect of tetracaine on intraocular pressure (IOP) in normal 
and hypertensive rabbit eyes.
Methods: The study was conducted on 12 healthy rabbits as controls and 6 healthy 
rabbits in which an experimental model of ocular hypertension (OHT) was induced 
by administration of 70 mL/kg of tap water through an orogastric tube. One drop 
of tetracaine was instilled in the left eye while a drop of normal saline (placebo) was 
applied to the right eye of the control group. IOP was measured before and 0, 5, 10, 
15, 20, 25, 30, 35 and 40 minutes after drop administration in this group. The OHT 
group also received one drop of tetracaine and normal saline in the left eyes and 
right eyes respectively, immediately after water loading; the instillation of drops was 
repeated after 55 minutes. IOP was measured before and 0, 5, 10, 15, 20, 25, 30, 35, 
40, 55, 70, 85, 100 and 115 minutes after water loading in this group. 
Results: Tetracaine treated eyes in both groups (ocular hypertensive and normal 
controls) demonstrated significant IOP reduction at time zero (immediately after 
drop instillation) which was sustained up to 20 minutes, as compared to placebo 
treated eyes (P<0.05). In ocular hypertensive rabbits, repeat instillation of tetracaine 
significantly reduced IOP at 55 minutes up to 30 minutes thereafter.
Conclusion: Topical tetracaine can reduce IOP; this fact should be considered in 
experiments evaluating IOP reducing agents.
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INTRODUCTION
Topical anesthetics are used for many diagnostic 
and therapeutic ocular procedures such as 
intraocular pressure (IOP) measurement in 
humans and animals.1-4 The two most commonly 
used topical anesthetics are proparacaine and 
tetracaine.4 It has previously been reported 
that topical anesthetics may reduce IOP.1,2,5-7 
Although these agents are commonly used in 
everyday practice, the use of topical anesthetics 
may interfere with results of investigations 
designed to evaluate the effect of different 
drugs or interventions on IOP.
Experimental ocular hypertension (OHT) 
can be created by administration of tap water via 
an orogastric tube, which induces acute ocular 
hypertension lasting up to 2 hours. This model 
is used for evaluating drugs that act on outflow 
facility or the production of aqueous humor.8 To 
the best of our knowledge, there are no reports 
on the effect of tetracaine on IOP. This study Tetracaine and IOP in Rabbits; Sarchahi et al
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was designed to evaluate the effect of tetracaine 
on IOP in healthy rabbit eyes and to compare it 
to the corresponding effect in an experimental 
model of ocular hypertension.
METHODS
Twelve adult white New Zealand rabbits, 
including six male and six female animals, 
weighing 1-3 kg (mean weight, 1.77±0.53 kg) 
with normal eye examinations including slit 
lamp biomicroscopy, ophthalmoscopy and 
tonometry were used for the purpose of this 
study. The study was approved by the Research 
Animal Care and Use Committee at the School 
of Veterinary Medicine, Shiraz University and 
complied with the ARVO Statement for the Use 
of Animals in Ophthalmic and Vision Research. 
The animals were maintained for one week in a 
standard room on a 12 hour light-dark schedule 
to adjust to the environment and were provided 
with food and water ad libitum. During this 
period, IOP was measured daily to make the 
animals familiar with tonometry.
In order to test the drug in healthy rabbits, 
one drop of 0.5% tetracaine hydrochloride 
(Anestocaine, Sinadaru, Iran) was instilled in 
the left eyes (normal group, treatment eye) and 
one drop of normal saline was applied in the 
right eyes (normal group, placebo eye). IOP was 
measured before and 0, 5, 10, 15, 20, 25, 30, 35 
and 40 minutes after drop administration using 
an electronic applanation tonometer (Tonopen 
VET, Reichert Inc., NY, USA). In order to 
study the effect of tetracaine in conditions of 
abnormality, ocular hypertension was induced 
in six healthy rabbits by the administration of 
70 mL/kg of tap water via an orogastric tube. 
The left eyes of this group received one drop of 
tetracaine 0 and 55 minutes after water loading 
(OHT group, treatment eye) and the right eyes 
received a drop of normal saline at the same 
intervals (OHT group, placebo eye). IOP was 
measured before and 0, 5, 10, 15, 20, 25, 30, 35, 
40, 55, 70, 85, 100 and 115 minutes after water 
loading. The time at which the palpebral reflex 
was observed (return of ocular sensation), was 
also recorded.
Paired t-test was used to compare mean IOP 
between the study groups. P values less than 
0.05 were considered as statistically significant. 
RESULTS
Diurnal variation
Mean diurnal IOP changes in healthy rabbits are 
displayed in figure 1. Maximum and minimum 
IOP values were recorded at 9 am and 10 pm, 
respectively in both eyes. Mean maximum IOP 
was 13.6±2.9 mmHg in right eyes and 13.4±3.0 
mmHg in left eyes. Mean minimum IOP was 
9.1±1.6 mmHg in right eyes and 9.3±1.7 mmHg 
in left eyes. No significant difference was 
observed between the two eyes of this group 
at any time point (P>0.05). 
IOP lowering effect of 0.5% tetracaine in 
normotensive eyes
Mean baseline IOP values before drop 
instillation in treated and placebo eyes of 
Figure 1. Diurnal variation of mean intraocular pressure (IOP) in normotensive rabbits. Maximum IOP occurred at 9 
am and minimum IOP occurred at 10 pm. No significant difference was observed between the two eyes at any time 
point.Tetracaine and IOP in Rabbits; Sarchahi et al
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the normal control group were 17.5±2.6 and 
18.1±3.3 mmHg, respectively (P>0.05). At time 
zero (immediately after drop instillation), mean 
IOP of treated eyes reached 12.5±2.1 mmHg 
reflecting a 28.6% decrease from baseline values 
(P<0.001). This IOP reduction continued up 
to 10 minutes after drug administration and 
then started to increase, but was significantly 
lower than baseline up to 20 minutes after 
drug administration (P<0.01). When compared 
to placebo eyes, IOP reduction in treated eyes 
was significant at time zero until 20 minutes 
after drug instillation (P<0.01). The peak IOP 
reducing effect of tetracaine (5.2 mmHg, 29.1%) 
was observed 10 minutes after instillation 
(Fig. 2). Mean IOP reduction in treated eyes 
as compared to placebo eyes at times 0, 5, 10, 
15 and 20 minutes was 4.3 (25.6%), 3.8 (23.2%), 
5.2 (29.1 %), 3 (17.3%), and 3 (16.8%) mmHg, 
respectively. 
IOP lowering effect of 0.5% tetracaine in 
ocular hypertensive eyes
As shown in figure 3, mean baseline IOP values 
of treated and placebo eyes before water loading 
were 16.7±3.3 and 16.8±2.5 mmHg (P>0.05), 
respectively. At time zero (immediately after 
water loading and drug instillation), mean IOP 
decreased to 9.7±1.8 mmHg (41.3% reduction, 
p=0.001) in the treated group and to 12.8±3.0 
mmHg (23.8% reduction, P=0.012) in the placebo 
group. Thereafter, mean IOP started to increase 
in both eyes, but the rate of IOP increase in 
treated eyes was lower than that in placebo 
eyes. Mean IOP in placebo eyes increased to 
24.3±4.8 mmHg (44.6%) 20 minutes after water 
loading (P=0.009) and reached its maximum 
(27.7± 5.7 mmHg, 64.9% increase) 35 minutes 
after water loading. It then decreased gradually 
and reached baseline values 70 minutes later. 
Figure 2. Effect of tetracaine on mean intraocular pressure (IOP) in 12 normotensive rabbits. Data are expressed in 
mean±standard deviations. Tetracaine was instilled in treated eyes at time zero. IOP decreased immediately after 
tetracaine instillation lasting for 20 minutes in treated eyes (*P<0.01, **P<0.001).
Figure 3. Effect of tetracaine on intraocular pressure (IOP) in 6 ocular hypertensive rabbits. Data are expressed in 
mean±standard deviations. Tetracaine was instilled in treated eyes 0 and 55 minutes after water loading; IOP decreased 
immediately after tetracaine instillation up to 20 and 30 minutes later, respectively (*P<0.05, **P<0.01).Tetracaine and IOP in Rabbits; Sarchahi et al
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Mean IOP in treated eyes, similar to placebo 
eyes, increased gradually but at a significantly 
lower rate 5, 10, 15, and 20 minutes after water 
loading. Mean IOP rise in treated eyes at the 
above-mentioned intervals was 5.1 (30.4%), 
6.3 (31%), 5.8 (27.6%) and 5.8 (23.9%) mmHg, 
respectively. Another drop of tetracaine was 
instilled in the left eyes 55 minutes after water 
loading to investigate the effect of tetracaine 
on pre-increased IOP. At this time, a sudden 
drop of IOP to 16.3±5 mmHg was observed (6.7 
mmHg reduction, 29.1%, P=0.026,) in treated 
eyes as compared to placebo eyes. IOP remained 
significantly lower in treated eyes as compared 
to placebo eyes up to 85 minutes (P<0.05).
Loss of corneal sensation (eyelid blinking) 
was observed immediately after instillation 
of tetracaine in both normotensive and 
hypertensive eyes. Corneal sensation returned 
20 and 22 minutes after drug administration 
in normotensive and hypertensive eyes, 
respectively (P>0.05).
DISCUSSION 
Tetracaine is a potent ester-type local 
anesthetic agent. It is usually used topically in 
ophthalmology; it has also been used for spinal 
anesthesia.4,9 It acts by reversibly stabilizing 
voltage-dependent sodium ion channels, 
decreasing their permeability to sodium ions 
and thus blocking the initiation and conduction 
of sensory nerve impulses to the spinal cord 
and brain stem.2,4 
In the present study, topical tetracaine led 
to IOP reduction in both normotensive and 
hypertensive eyes in an experimental rabbit 
model. IOP decrease in both groups was 
observed immediately after drug instillation 
and was continued up to 20 minutes later. The 
absolute level of IOP reduction in hypertensive 
eyes exceeded that in normotensive eyes, but 
no difference was noted in the percentage of 
reduction. This may be due to higher baseline 
IOP in hypertensive eyes.8 Repeat instillation of 
tetracaine at 55 minutes, resulted in a further 
significant IOP reduction which was continued 
up to 30 minutes thereafter. This observation 
shows that tetracaine, in addition to preventing 
IOP rise, can also reduce established high IOP. 
To the best of our knowledge, there are no 
other reports on the effect of tetracaine on IOP in 
humans or animals and the exact mechanisms of 
its effect are unclear. Some reports have shown 
that other topical anesthetics can reduce IOP.1,2,5-7 
Baudouin and Gastaud1 reported significant IOP 
reduction using oxybuprocaine and betoxycaine. 
They reported IOP reduction to start one minute 
after instillation and to be continued for at least 
15 minutes which is similar to our results.
Some studies have reported a relationship 
between IOP and central corneal thickness.10,11 
Asensio et al5 reported that the IOP-lowering 
effect of oxybuprocaine is due to a decrease 
in corneal thickness, whereas in the study 
by Montero et al,6 IOP decreased without 
any change in corneal thickness. The latter 
investigators used a non-contact tonometer and 
reported that a combination of tetracaine and 
oxybuprocaine caused a significant reduction in 
IOP up to 5 minutes after drug instillation. They 
also measured corneal thickness and reported 
that this combination of topical anesthetics did 
not alter corneal thickness. 
In contrast to these reports, in a study by 
Ehongo et al3 who used oxybuprocaine and 
measured IOP using a contact tonometer, IOP did 
not significantly change as compared to baseline 
values two minutes after drug instillation. 
Some reasons that may explain the 
mechanism of IOP reduction by topical 
anesthetics include reduced lid squeezing6,12 or 
breath holding by the patient in preparation for 
the procedure,6 softening of the cornea by topical 
anesthesia,13 and relaxation of the eyeball and 
ciliary muscles (since extraocular muscle tone 
and scleral rigidity can also affect IOP)14.
The actual effect of topical anesthetics on 
IOP can only be demonstrated by non-contact 
tonometers that do not require the use of 
anesthetics.6 Though non-contact tonometers 
have gained widespread acceptance, the 
consensus is that contact tonometry is more 
accurate and should be employed to confirm 
readings obtained by the former methods and is 
the preferred technique for IOP measurment.2 In 
the present study, we used a contact tonometer 
(Tonopen VET, Reichert Inc., NY, USA) which Tetracaine and IOP in Rabbits; Sarchahi et al
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is an easy-to-use, hand-held instrument that 
provides accurate IOP readings for veterinary 
uses.15,16 As topical anesthetics were not used in 
some eyes (placebo eyes), there were some cases 
of eyelid blinking, but the contact tonometer 
was used with no problem and did not cause 
major discomfort for the rabbits; furthermore, 
no considerable changes were observed in IOP 
throughout the study.
In summary, it seems that topical tetracaine 
seems to reduce IOP and therefore may interfere 
with the results of experiments that evaluate the 
effect of medications or interventions on IOP. In 
these studies, part of the IOP reduction may be 
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